IN8bio cuts staff and pipeline to focus on AML cell therapy

Sep 6, 2024 - 04:00

IN8bio cuts staff and pipeline to focus on AML cell therapy

Read the original article

Tags:

Previous Article

eGenesis scoops $191m for genetically modified pig kidney transplant trial

NHS England offers MSD belzutifan for von Hippel-Lindau disease

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Genentech buys Regor’s CDK inhibitors in $850m deal

Genentech buys Regor’s CDK inhibitors in $850m deal

Oct 2, 2024

The Canada wildfires are exposing the harmful effects — and health inequities — of air pollution

The Canada wildfires are exposing the harmful effects —...

Jun 8, 2023

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of ta...

Dec 1, 2023